Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ZIVO Bioscience, Inc. (ZIVO : OTC)

• Company Description    Zivo Bioscience Inc., is a R&D firm. It engaged in study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. Zivo Bioscience Inc. is headquartered in Keego Harbor, Michigan. Number of Employees: 5

• Price / Volume Information    Yesterday's Closing Price: $6.25 Daily Weekly Monthly 20 Day Moving Average: 768 shares Shares Outstanding: 4.22 (millions) Market Capitalization: $26.34 (millions) Beta: 0.38 52 Week High: $17.50 52 Week Low: $1.11 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 73.61% 75.44% 12 Week 56.25% 52.44% Year To Date -28.16% -36.85%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2804 ORCHARD LAKE ROAD SUITE 210 A - KEEGO HARBOR,MI 48320 USA ph: 248-452-9866 fax: - vcervantes@allianceadvisors.com http://www.zivobioscience.com

• General Corporate Information    Officers John B. Payne - Chief Executive Officer; President and Director GuillermoNavarro - Chief Financial Officer Christopher D. Maggiore - Director Laith Larry Yaldoo - Director Alison A. Cornell - Director Peer Information ZIVO Bioscience, Inc. (CORR.) ZIVO Bioscience, Inc. (RSPI) ZIVO Bioscience, Inc. (CGXP) ZIVO Bioscience, Inc. (BGEN) ZIVO Bioscience, Inc. (GTBP) ZIVO Bioscience, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 98978N309 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/13/26 Share - Related Items Shares Outstanding: 4.22 Most Recent Split Date: 10.00 (0.17:1) Beta: 0.38 Market Capitalization: $26.34 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 72.09% vs. Previous Quarter: 50.00% Sales Growth vs. Year Ago Period: 106.25% vs. Previous Quarter: 24.53% ROE 09/30/26 - - 06/30/26 - - 03/31/26 - - ROA 09/30/26 - - 06/30/26 - -1,008.52 03/31/26 - -1,085.88 Current Ratio 09/30/26 - - 06/30/26 - 0.10 03/31/26 - 0.07 Quick Ratio 09/30/26 - - 06/30/26 - 0.03 03/31/26 - 0.00 Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - -8,339.40 03/31/26 - -5,573.11 Book Value 09/30/26 - - 06/30/26 - -0.80 03/31/26 - -0.86 Inventory Turnover 09/30/26 - - 06/30/26 - 0.22 03/31/26 - 0.61 Debt-to-Equity 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Capital 09/30/26 - - 06/30/26 - - 03/31/26 - -

Powered by Zacks Investment Research ©